NOTES PAYABLE - Loan and Security Agreement (Details) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
|
Sep. 27, 2023
USD ($)
item
$ / shares
|
Jun. 30, 2026
USD ($)
shares
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
shares
|
Jun. 30, 2025
USD ($)
|
May 18, 2026
USD ($)
|
Apr. 10, 2026
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| NOTES PAYABLE | ||||||||
| Interest expense | $ 446,179 | $ 87,844 | $ 782,333 | $ 169,167 | ||||
| Notes Payable | 1,687,792 | 1,687,792 | $ 6,143,837 | |||||
| Debt discount on note payable | $ 64,566 | 6,927 | 86,280 | 16,063 | ||||
| Amortization of debt issuance costs | $ 327,729 | 20,244 | ||||||
| Exercised warrants of preferred stock | shares | 1,614,603 | 1,614,603 | ||||||
| Loan security agreement | ||||||||
| NOTES PAYABLE | ||||||||
| Notes Payable | $ 0 | |||||||
| Interest expense | $ 72,188 | $ 73,792 | $ 103,469 | $ 145,979 | ||||
| Debt face amount | $ 5,000,000 | $ 3,500,000 | ||||||
| Debt, floating rate | 8.36% | 8.36% | 8.36% | 8.36% | 8.61% | |||
| Convertible warrants, number of shares | item | 197,551 | |||||||
| Exercise price per share | $ / shares | $ 0.35 | |||||||
| Loan security agreement | Expected volatility | ||||||||
| NOTES PAYABLE | ||||||||
| Fair value of warrants | $ 55,330 | |||||||
| Loan security agreement | Minimum | ||||||||
| NOTES PAYABLE | ||||||||
| Debt, floating rate | 8.25% | |||||||
| Term A | ||||||||
| NOTES PAYABLE | ||||||||
| Debt face amount | $ 3,500,000 | |||||||
| Term B | ||||||||
| NOTES PAYABLE | ||||||||
| Debt face amount | $ 1,500,000 | |||||||
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of amortization expense attributable to debt issuance costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|